CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The VASPRINT project focuses on creating advanced tumor models to study the effects of vascular architecture on immune cell behavior in cancer treatment. By combining bioprinting and self-assembly techniques, it aims to enhance the understanding of immunotherapy for solid tumors.
Cancer is a global challenge.
Addressing this, the EU Mission on Cancer aims to improve the lives of >3 million people by 2030.
To achieve this goal requires not only new treatments, but also new in vitro platforms to study how their efficacy can be maximised.
Cancer immunotherapy has been a promising treatment for certain haematological cancers, but is encountering tremendous challenges when used for solid cancers.
One of the main reasons is that tumours are often protected by an immunosuppress…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
United States, Cambridge
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
